Accelerate Diagnostics

Accelerate Diagnostics, Inc. is a clinical microbiology company based in Tucson, Arizona. It specializes in developing and commercializing rapid diagnostic systems for infectious diseases. Originally founded in 1982 as Sage Resources Corp., the company has evolved to focus on innovative technologies for serious infections through strategic acquisitions. The flagship product, the Accelerate Pheno system, is an automated in vitro diagnostic platform that provides rapid bacterial identification and antimicrobial susceptibility testing. This system delivers actionable results in approximately 6 to 8 hours, significantly faster than traditional methods. It is FDA-cleared and CE marked for use in the U.S. and European markets. The technology is designed for healthcare facilities, including hospitals and clinical laboratories, to enhance the diagnosis and treatment of bloodstream infections and antimicrobial resistance. Accelerate Diagnostics aims to improve patient outcomes by leveraging advanced molecular diagnostic methods and proprietary technologies. The company is publicly traded on NASDAQ under the ticker symbol AXDX and reported net sales of $11.7 million for the full year 2024.

• Employees 110
• Founded 2004
• Annual Revenue $11698000
• Total Funding $115980600